EB-1053

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEB-1053
Drug Alias NameEB-1053
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone resorption factor inhibitors
TargetsBone resorption factor
Therapy Area/IndicationsHypercalcemiaOsteitis Deformans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeo Pharma Inc
Active IndicationsN/A
Inactive IndicationsHypercalcemiaOsteitis Deformans

Other Information

ATC CodeN/A
Related LinksN/A